Targovax to hold a webcast with Q&A session
Oslo, Norway, 25 March 2019 - Targovax ASA (OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard-to-treat solid tumors, announces that the Company on Thursday 28 March 2019 13:00 (CET) will hold a live Q&A session with Targovax's senior management. The Q&A session will streamed at Aksjeforum. Please follow this link: http://bit.ly/2HPDTd5 We welcome questions before and during the session. Please send questions in advance to contact@targovax.com (mail%20to:%20contact@targovax.com) or post them in the commentary field below the stream during